<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02737735</url>
  </required_header>
  <id_info>
    <org_study_id>SBao-guo</org_study_id>
    <nct_id>NCT02737735</nct_id>
  </id_info>
  <brief_title>The Effect on Decreasing Chemotherapeutic Toxicity and Increasing Anti-tumor Effect of Chinese Herbs Based on Syndrome Differentiation</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>First Affiliated Hospital, Sun Yat-Sen University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>First Affiliated Hospital, Sun Yat-Sen University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To study the effect on decreasing chemotherapeutic toxicity and increasing anti-tumor
      treatment of Chinese Herbs based on syndrome differentiation
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>March 2016</start_date>
  <completion_date type="Anticipated">January 2020</completion_date>
  <primary_completion_date type="Anticipated">December 2019</primary_completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Overall survival rate</measure>
    <time_frame>36months</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>progression-free survival rate</measure>
    <time_frame>36months</time_frame>
  </primary_outcome>
  <other_outcome>
    <measure>Quality of Life Questionnaire (EORTC QLQ C30)scores</measure>
    <time_frame>36months</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>RECIST(Response Evaluation Criteria In Solid Tumors)</measure>
    <time_frame>36months</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>KPS scores</measure>
    <time_frame>36months</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>nutritional evaluation scores</measure>
    <time_frame>36months</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>BMS(Bone marrow suppression) scores</measure>
    <time_frame>36months</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Gastrointestinal reactions scores</measure>
    <time_frame>36months</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>hair loss level scores</measure>
    <time_frame>36months</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>AST value</measure>
    <time_frame>36months</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>ALT value</measure>
    <time_frame>36months</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>creatinine value</measure>
    <time_frame>36months</time_frame>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Carcinoma, Non-Small-Cell Lung</condition>
  <arm_group>
    <arm_group_label>Chemotherapy combined with compound herbal medicine</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Standard chemotherapy protocols on phase IIIB/IV non-small-cell lung cancer for 24 weeks combined with compound Chinese herbal medicine for 2 years，which include 15 kinds of Chinese herbs:Thunberg fritillary bulb,antimutangenic ,cimicifuga foetida,astragalus,pinellia ,Radix Ophiopogonis ,Solanum nigrum,Hedyotis diffusa,Prunella vulgaris ,cordate houttuynia,Herba Patriniae,dried orange peel ,Codonopsis,Wolfiporia extensa,Coix seed,Rhizoma Alismatis.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Chemotherapy</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The therapy of standard chemotherapy protocols on phase IIIB/IV non-small-cell lung cancer for 24 weeks</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>standard chemotherapy medicine combined with Chinese herbs</intervention_name>
    <arm_group_label>Chemotherapy combined with compound herbal medicine</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>standard chemotherapy medicine</intervention_name>
    <arm_group_label>Chemotherapy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Histology and cytology diagnosed IIIB or IV non-small-cell lung cancer (NSCLC) and
             untreated; Age &gt; 18 ages

          -  Sex unlimited; ECOG (Eastern Cooperative Oncology Group) fitness score (Performance
             status, PS)≤2.

          -  White blood cell count ≥ 3 x 10E9 / L, neutrophils ≥1 x 109 p/L, hemoglobin≥80 g/L ,
             platelet ≥100 x 10E9 / L

          -  ALT, AST, normal or less than 2 times, bilirubin is normal

          -  Serum level in the normal range;Thr ecg is normal

          -  Expected survival time≥ 3 months or more;

          -  Agreed to the treatment combined traditional Chinese medicine with western medicine

        Exclusion Criteria:

          -  Engaged in other clinical subjects

          -  Pregnant or lactating women, women in childbearing age refuse contraceptives during
             the trail

          -  Severe pneumonia, tuberculosis, lung abscess, myocarditis and other malignant tumor

          -  Severe damage of heart, liver and kidney (cardiac function grade 3 ~ 4, ALT and/or AST
             2 times more than normal , Cr more the normal limit)

          -  Mental illness, Refused to partner; Cannot obtain informed consent
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Bao-guo Sun, doctor</last_name>
    <phone>13316134352</phone>
    <email>Sunbaoguo666@126.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Xin Zhou, master</last_name>
    <phone>13533259616</phone>
    <email>myeva520@163.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>The First Affiliated Hospital of Sun-yat Sen University</name>
      <address>
        <city>GuangZhou</city>
        <state>Guangdong</state>
        <zip>510080</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bao-guo Sun, doctor</last_name>
      <phone>13316134352</phone>
      <email>Sunbaoguo666@126.com</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>March 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 26, 2016</study_first_submitted>
  <study_first_submitted_qc>April 9, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 14, 2016</study_first_posted>
  <last_update_submitted>April 9, 2016</last_update_submitted>
  <last_update_submitted_qc>April 9, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 14, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>First Affiliated Hospital, Sun Yat-Sen University</investigator_affiliation>
    <investigator_full_name>Sun Bao-guo</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Carcinoma, Non-Small-Cell Lung</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

